CorWave Presents an Unprecedented Chronic In Vivo Study at the 41st Annual Meeting of the International Society of Heart and Lung Transplantation

By stepworks_adminApril 27, 2021November 6th, 2024Healthcare

No Comments

CorWave Presents an Unprecedented Chronic In Vivo Study at the 41st Annual Meeting of the International Society of Heart and Lung Transplantation

https://www.corwave.com/wp-content/uploads/2021/04/20210427_CorWave_PR_ISHLT.pdf

Tags:

Healthcare CorWave

PreviousPublication of 1-year Outcomes from PROMISE I of LIMFLOW System Demonstrates Excellent Sustained AFS and Wound Healing in No-option CLTI Patients
NextLimFlow Receives Japan PMDA Approval for Clinical Study of Minimally Invasive Technology Designed to Prevent Amputations in CLTI Patients

M&L GROUP

We are a family investment firm that cultivates pioneering ventures into successful enterprises with passion, energy and integrity.

Hospitality

Healthcare

Shipping

Alternatives

Media room

About

Contact

Copyright © 2025 M&L Group. All Rights Reserved. | Legal.

Branding and website design by Stepworks